Manuscripts
Showing 1587 manuscripts.
Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.
Citation
Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.. Journal of Allergy and Clinical Immunology. 2011. 128PMID: 21752440Year
2011
Journal
Journal of Allergy and Clinical Immunology
Upregulation of IL-21 Receptor on B cells and IL-21 secretion distinguishes H1N/09 vaccine responders from non-responders among HIV infected persons on combination antiretroviral therapy.
Citation
Upregulation of IL-21 Receptor on B cells and IL-21 secretion distinguishes H1N/09 vaccine responders from non-responders among HIV infected persons on combination antiretroviral therapy.. Journal of Immunology. 2011. 186PMID: 21531891Year
2011
Journal
Journal of Immunology
Association of recent HIV infection and in-utero HIV-1 transmission.
Citation
Association of recent HIV infection and in-utero HIV-1 transmission.. AIDS. 2011. 25: 1357-64. PMID: 21572305Year
2011
Journal
AIDS
Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.
Citation
Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.. Journal of Clinical Microbiology. 2011. 49PMID: 21956987Year
2011
Journal
Journal of Clinical Microbiology
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial
Citation
Donna Mildvan, Charles Flexner, Camlin Tierney, Robert Gross, Adriana Andrade, Christina M. Lalama, Susan H. Eshleman, Judith A. Aberg, Ian M. Sanne, Teresa Parsons, Angela D.M. Kashuba, Susan L Rosenkranz, Anne Kmack, Elaine Ferguson, Marjorie Dehlinger. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clinical Infectious Diseases. 2010. 50: 1041-52. PMID: 20192725Year
2010
Journal
Clinical Infectious Diseases
Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV
Citation
Timothy Schacker, Ronald J. Bosch, Kara Bennett, Richard B. Pollard, Gregory K. Robbins, Ann C. Collier, Roy (Trip) Gulick, John Spritzler, Donna Mildvan. Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. Journal of Acquired Immune Deficiency Syndromes. 2010. 54: 59-62. PMID: 20182359Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs
Citation
Mina John, David Heckerman, Larry Park, Ian James, Jonathan Carlson, Abha Chopra, Silvana Gaudieri, David Nolan, Sharon A. Riddler, Richard H. Haubrich, Simon Mallal. Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs. Journal of Immunology. 2010. 184: 4368-77. PMID: 20231689Year
2010
Journal
Journal of Immunology
No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.
Citation
Rajesh Gandhi, Ronald J. Bosch, Evgenia Aga, Mary Albrecht, Lisa M. Demeter, Carrie Dykes, Barbara Bastow, Michael F. Para, J. P. Lai, Robert F. Siliciano, Janet M. Siliciano, Joseph J. Eron. No evidence for decay of the latent reservoir in HIV-1-infected patients receiving intensive enfuvirtide-containing antiretroviral therapy.. Journal of Infectious Diseases. 2010. 201: 293-6. PMID: 20001856Year
2010
Journal
Journal of Infectious Diseases
Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate
Citation
Athe Tsibris. Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 420-7. PMID: 20856130Year
2010
Journal
Journal of Acquired Immune Deficiency Syndromes
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens
Citation
Kenneth E. Sherman, Susan D. Rouster, S. Stanford, Jason T. Blackard, Norah Shire, Margaret James Koziel, Marion G. Peters, Raymond T. Chung. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. Journal of Infectious Diseases. 2010. 201: 712-9. PMID: 20105080Year
2010
Journal
Journal of Infectious Diseases